BIO2013 Fellowship Winner – Roland Steck

Every year, IHBI, bluebox and QUT’s Division of Research and Commercialisation sponsor three early- to mid-career researchers to attend the Biotechnology Industry Organisation (BIO) conference in the USA. This year, Dr Melissa Fernandez, Dr Roland Steck and Dr Eliza Whiteside have been selected as thRoland Stecke 2013 BIO Fellows. Today we will meet Dr Roland Steck.

Dr Steck is the Deputy Director of the Medical Engineering Research Facility (MERF) at QUT, and a Senior Research Fellow in the Trauma Research Group at QUT’s Institute of Health and Biomedical Innovation (IHBI). Roland joined QUT in 2005 to establish the research program for the Chair of Trauma, Prof. M. Schuetz. This research group now conducts experimental research and develops computational simulation methods to study and improve bone fracture and defect healing. Roland’s own research interests include the development and characterisation of novel fracture fixation implants for murine models of diaphyseal and metaphyseal bone fracture healing, as well as new experimental models of soft tissue trauma. For this and other related research he has established advanced evaluation protocols mechanical testing and microCT. In 2011, he was appointed as Deputy Director of MERF, a state-of-the-art research and teaching facility with surgical theatres for pre-clinical studies, research laboratories and surgical skills laboratories. In this role, Roland works on developing MERF into a technology rich interface between the health community and industry by providing a research and training environment that facilitates the translation of novel concepts from basic research to clinical implementation.

http://www.linkedin.com/pub/roland-steck/9/994/227

BIO is the largest biotechnology conference in the world, with approximately 16,500 attendees expected to attend this year’s event in Chicago. Along with a feature-packed conference program, BIO also offers a one-on-one BIO Business Forum and an exhibition hall with over 1,600 companies showcasing their latest products and technologies. BIO covers the complete spectrum of life sciences areas and biotechnology applications. From drug discovery to biomanufacturing, genomics to biofuels, cell therapy to nanotechnology – BIO has it covered.